Solube receptor for advanced glycation end products in patients with renal impairment and hemodialysis patients /
المستقبلات الذاتية لنواتج التسكير النهائية المتقدمة فى مرضى قصور وظائف الكلى ومرضى الغسيل الكلوى
Ahmed Farag Ahmed ; Supervised Hanan Abdelhalim Abdelrahim , Mona Mohamed Roshdy , Layila Rashed
- Cairo : Ahmed Farag Ahmed , 2011
- 114 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
Solube RAGE is a naturally occurring inhibitor of pathological effects mediated via RAGE . Protective sRAGE levels are decreased in patients with coronary artery disease as well as in patients with hypertension . Patients with decrease renal function arre at high cardiovascular risk and often have hypertension or diabetes factors that decrease renal function
Glycation end products Hemodialysis patients Renal impairment